Literature DB >> 18191360

Candida lusitaniae septic arthritis: case report and review of the literature.

Jeremy Ryan Bariola1, Michael Saccente.   

Abstract

Candida lusitaniae is an infrequently encountered Candida species that has been associated with resistance to amphotericin B. We present a case of septic arthritis with C. lusitaniae and provide a brief review of the organism, especially in regard to current information about its pattern of resistance to antifungal agents.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18191360     DOI： 10.1016/j.diagmicrobio.2007.12.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  4 in total

1.  Usefulness of McRAPD for typing and importance of biofilm production in a case of nosocomial ventriculoperitoneal shunt infection caused by Candida lusitaniae.

Authors:  Petr Hamal; Juraj Hanzen; Frantisek Horn; Jitka Trtkova; Lenka Ruskova; Renata Vecerova; Filip Ruzicka; Anna Vollekova; Vladislav Raclavsky
Journal:  Folia Microbiol (Praha)       Date:  2011-09-06       Impact factor: 2.099

2.  Fungal arthritis of the hip in patient with aplastic anaemia.

Authors:  Ronan Le Calloch; Jean-Christophe Ianotto; Gaëlle Guillerm; Jean Marie Tonnelier
Journal:  BMJ Case Rep       Date:  2013-08-13

3.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

4.  Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.

Authors:  Deborah A Hogan; Sven D Willger; Emily L Dolben; Thomas H Hampton; Bruce A Stanton; Hilary G Morrison; Mitchell L Sogin; Julianna Czum; Alix Ashare
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.